Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control
Authors:
- F. LasneFLF. Lasne
- L. MartinLML. Martin
- J. A. MartinJMJ. A. Martin
- J. de CeaurrizJCJ. de Ceaurriz
- 29 May 2009
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (6) , 888-890
Abstract
Anti-doping control of erythropoietin (Epo) relies on the differentiation by isoelectric profile of natural endogenous hormone from the recombinant hormone used for doping. The first and second generations of recombinant Epo were detectable in urine.[1][1],[2][2] The third generation, ContinuousKeywords
This publication has 8 references indexed in Scilit:
- Isoelectric profiles of human erythropoietin are different in serum and urineInternational Journal of Biological Macromolecules, 2007
- Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting proceduresJournal of Immunological Methods, 2003
- Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormonesAnalytical Biochemistry, 2002
- Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting proceduresJournal of Immunological Methods, 2001
- Recombinant erythropoietin in urineNature, 2000
- Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humansAmerican Journal of Physiology-Renal Physiology, 1988
- The influence of work intensity on postexercise proteinuriaEuropean Journal of Applied Physiology, 1988
- Renal responses to various rates of exercise.Journal of Applied Physiology, 1970